Yes I agree, it's not the complete pasting we usually get from AFR.
Tribeca obviously don't cover MSB and have not drilled down into the other potential income streams of MSB's cells, completely different to Burman Invest ( Julia Lee ) who have allocated 6% the max for a spec share allowed in their fund.
Cheers BK14
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-239
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
-0.020(2.12%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 92.0¢ | $2.103M | 2.270M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 106422 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 59027 | 3 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |